These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
400 related items for PubMed ID: 31939197
1. Effects of renin-angiotensin system blockers on renal and cardiovascular outcomes in patients with diabetic nephropathy: a meta-analysis of randomized controlled trials. Liu X, Ma L, Li Z. J Endocrinol Invest; 2020 Jul; 43(7):959-972. PubMed ID: 31939197 [Abstract] [Full Text] [Related]
2. Individualized prediction of the effect of angiotensin receptor blockade on renal and cardiovascular outcomes in patients with diabetic nephropathy. van der Sande NG, Dorresteijn JA, Visseren FL, Dwyer JP, Blankestijn PJ, van der Graaf Y, Heerspink HL. Diabetes Obes Metab; 2016 Nov; 18(11):1120-1127. PubMed ID: 27337598 [Abstract] [Full Text] [Related]
4. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease. Sharma P, Blackburn RC, Parke CL, McCullough K, Marks A, Black C. Cochrane Database Syst Rev; 2011 Oct 05; (10):CD007751. PubMed ID: 21975774 [Abstract] [Full Text] [Related]
9. Reno-protective effects of renin-angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis. Vejakama P, Thakkinstian A, Lertrattananon D, Ingsathit A, Ngarmukos C, Attia J. Diabetologia; 2012 Mar 05; 55(3):566-78. PubMed ID: 22189484 [Abstract] [Full Text] [Related]
15. Renoprotective Effect of the Combination of Renin-angiotensin System Inhibitor and Calcium Channel Blocker in Patients with Hypertension and Chronic Kidney Disease. Huang RS, Cheng YM, Zeng XX, Kim S, Fu P. Chin Med J (Engl); 2016 Mar 05; 129(5):562-9. PubMed ID: 26904991 [Abstract] [Full Text] [Related]
16. ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3-5: A Network Meta-Analysis of Randomised Clinical Trials. Zhang Y, He D, Zhang W, Xing Y, Guo Y, Wang F, Jia J, Yan T, Liu Y, Lin S. Drugs; 2020 Jun 05; 80(8):797-811. PubMed ID: 32333236 [Abstract] [Full Text] [Related]
17. Is Chronic Kidney Disease Progression Influenced by the Type of Renin-Angiotensin-System Blocker Used? Silvariño R, Rios P, Baldovinos G, Chichet MA, Perg N, Sola L, Saona G, De Souza N, Lamadrid V, Gadola L. Nephron; 2019 Jun 05; 143(2):100-107. PubMed ID: 31203280 [Abstract] [Full Text] [Related]
18. Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Coronary Artery Disease without Heart Failure in the Modern Statin Era: a Meta-Analysis of Randomized-Controlled Trials. Hoang V, Alam M, Addison D, Macedo F, Virani S, Birnbaum Y. Cardiovasc Drugs Ther; 2016 Apr 05; 30(2):189-98. PubMed ID: 26861251 [Abstract] [Full Text] [Related]